Cargando…
Computational drug repurposing of Akt-1 allosteric inhibitors for non-small cell lung cancer
Non-small cell lung carcinomas (NSCLC) are the predominant form of lung malignancy and the reason for the highest number of cancer-related deaths. Widespread deregulation of Akt, a serine/threonine kinase, has been reported in NSCLC. Allosteric Akt inhibitors bind in the space separating the Pleckst...
Autores principales: | Baby, Krishnaprasad, Maity, Swastika, Mehta, Chetan Hasmukh, Nayak, Usha Y., Shenoy, Gautham G., Pai, Karkala Sreedhara Ranganath, Harikumar, Kuzhuvelil B., Nayak, Yogendra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188557/ https://www.ncbi.nlm.nih.gov/pubmed/37193898 http://dx.doi.org/10.1038/s41598-023-35122-7 |
Ejemplares similares
-
Targeting SARS-CoV-2 Main Protease: A Computational Drug Repurposing Study
por: Baby, Krishnaprasad, et al.
Publicado: (2021) -
Targeting SARS-CoV-2 RNA-dependent RNA polymerase: An
in silico drug repurposing for COVID-19
por: Baby, Krishnaprasad, et al.
Publicado: (2020) -
SARS-CoV-2 entry inhibitors by dual targeting TMPRSS2 and ACE2: An in silico drug repurposing study
por: Baby, Krishnaprasad, et al.
Publicado: (2021) -
Advances in targeting EGFR allosteric site as anti-NSCLC therapy to overcome the drug resistance
por: Maity, Swastika, et al.
Publicado: (2020) -
Identification of phytochemical as a dual inhibitor of PI3K and mTOR: a structure-based computational approach
por: Kumar, B. Harish, et al.
Publicado: (2022)